Zeronda Tyler 4
4 · VYNE Therapeutics Inc. · Filed Apr 3, 2024
Insider Transaction Report
Form 4
Zeronda Tyler
CHIEF FINANCIAL OFFICER
Transactions
- Tax Payment
Common Stock
2024-04-01$3.08/sh−94$290→ 131,743 total
Footnotes (1)
- [F1]Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units.